Cite
HARVARD Citation
Sweet, S. et al. (2022). CTOTC‐08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients. American journal of transplantation. 22 (1), pp. 230-244. [Online].